Concepedia

Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial

Meike H. van der Ree, J. Marleen de Vree, F. Stelma, Sophie B. Willemse, Marc van der Valk, Svend T. Rietdijk, Richard Molenkamp, Janke Schinkel, Ad C. van Nuenen, Ulrich Beuers,

The Lancet · 2017 · 268 citations · 29 references

DOI

Concepts

References

29

Silencing of microRNAs in vivo with ‘antagomirs’

Jan Krützfeldt, Nikolaus Rajewsky, Ravi Braich et al. · Nature · 2005 · 4K citations

, , +11

EASL Recommendations on Treatment of Hepatitis C 2018

Jean–Michel Pawlotsky, Francesco Negro, Alessio Aghemo et al. · Journal of Hepatology · 2018 · 2.8K citations

, , +14

Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA

Catherine L. Jopling, MinKyung Yi, Alissa M. Lancaster et al. · Science · 2005 · 2.5K citations

, , +17

Treatment of HCV Infection by Targeting MicroRNA

Harry L.A. Janssen, Hendrik W. Reesink, Eric Lawitz et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

, , +14

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

Christine Esau, Scott Davis, Susan Murray et al. · Cell Metabolism · 2006 · 2.1K citations · Full text

, , +16